Free Trial

Moleculin Biotech (MBRX) News Today

$4.40
-0.18 (-3.93%)
(As of 05/29/2024 ET)
Moleculin Biotech Inc (MBRX)
A Preview Of Moleculin Biotech's Earnings
Moleculin Announces Reverse Stock Split
Oppenheimer Keeps Their Buy Rating on Moleculin Biotech (MBRX)
Get Moleculin Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBRX and its competitors with MarketBeat's FREE daily newsletter.

Are You Positioned For The New Energy Goldrush? (Ad)

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.

MBRX Media Mentions By Week

MBRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MBRX
News Sentiment

1.25

0.78

Average
Medical
News Sentiment

MBRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MBRX Articles
This Week

3

1

MBRX Articles
Average Week

Get Moleculin Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MBRX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners